Popular heartburn drug may have given millions of people cancer, found contaminated with cancer chemical

Thursday, October 3, 2019
By Paul Martin

by: Ethan Huff
Thursday, October 03, 2019

Another Big Pharma drug is being pulled from pharmacy shelves after it was discovered that millions of people could have developed cancer from taking it.

Zantac and other ranitidine products are reportedly no longer available at CVS, which joined a handful other other retailers in suspending Zantac sales pending an investigation into “impurities” that could be linked to life-threatening side effects.

After both Canada and France issued official recalls of Zantac, the United States and the European Union decided to launch inquiries into the drug’s safety, which in turn has prompted some retailers to voluntarily stop selling Zantac until a conclusion is reached.

As usual, health authorities here in the U.S. claim that there’s “no immediate risk” from taking Zantac. But patients are being advised to contact their physicians to request prescription alternatives, if they’re available.

The FDA says cancer-causing chemicals in Zantac are “low,” so no mandatory recall is being issued

According to both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), Zantac and other drugs that contain ranitidine are also contaminated with a chemical compound known as N-nitrosodimethylamine, or NDMA, which is classified as a probable human carcinogen.

What this means, of course, is that taking drugs with NDMA in them could cause users to develop cancer over time, which is why some countries have mandated a recall. But the FDA insists that levels of NDMA in Zantac are “low,” and has thus not issued a mandatory recall.

But consumers are still being advised to seek alternatives, or to simply stop taking Zantac and all other ranitidine drugs. Keep in mind that Zantac is also linked to causing depression as well, which is another reason not to take it.

“Zantac brand products and CVS brand ranitidine products have not been recalled, and the FDA is not recommending that patients stop taking ranitidine at this time,” CVS revealed in a statement following its decision to suspend the sale of both Zantac and CVS Health brand ranitidine.

The company added that while a mandatory recall was not issued, CVS has chosen to cease sales until further notice “out of an abundance of caution.”

This decision by CVS came after Walgreens, Walmart, and Rite Aid had already made this same decision themselves in an effort to protect consumers against potential health risks.

A little bit of heartburn is probably better than a cancer diagnosis, wouldn’t you say?

The Rest…HERE

Leave a Reply

Join the revolution in 2018. Revolution Radio is 100% volunteer ran. Any contributions are greatly appreciated. God bless!

Follow us on Twitter